Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Accelerated approval plan for KRX-101

Nov. 14, 2002

Positive results from TA-1790 erectile dysfunction study

Nov. 13, 2002

Health Canada approves irbesartan for diabetic renal disease

Nov. 13, 2002

New PDE5 inhibitors in early development at Pfizer

Nov. 13, 2002

Series of PDE5 inhibitors in early development at Tanabe Seiyaku

Nov. 11, 2002

Potential of GPI-1046 for maintaining erectile function after radical prostatectomy

Nov. 6, 2002

Prostanoid IP antagonists and their use in bladder disorders reported by Roche

Nov. 6, 2002

Tadalafil reported safe and effective in broad-spectrum erectile dysfunction

Nov. 5, 2002

TAP Pharmaceutical submits NDA for Uprima for ED

Nov. 4, 2002

Promising laboratory results for phosphate-lowering RenaZorb

Nov. 4, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...